A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyelinating polyradiculoneuropathy and almost fully recovered after stopping tacrolimus and one course of intravenous immunoglobulin treatment. Unique features of this patient are the unusually long time lapse between initiation of tacrolimus and the adverse effect (10 years), a strong causality link and several arguments pointing toward an inflammatory etiology. When facing new neurological signs and symptoms in graft recipients, it is important to bear in mind the possibility of a drug-induced adverse event. Discontinuation of the suspect drug and immunomodulation are useful treatment options
Tacrolimus is an immunosuppressive agent that inhibitscytokine synthesis and blocks T-cell developme...
International audienceWhilst calcineurin inhibitors (CNI) are the cornerstone of immunosuppressive m...
Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant afte...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
Tacrolimus is an immunosuppressive agent that can show a wide variety of neurological side effects, ...
Abstract Background Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological...
Guillain-Barré syndrome (GBS) has been described after solid organ and bone marrow transplantation m...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Patients, in particular recipients of orthotopic liver transplants, receiving the immunosuppressant ...
Tacrolimus is currently the most commonly prescribed immunosuppressant. Tacrolimus allowed intestina...
Introduction. Optic neuropathy is a rare but severe complication of tacrolimus treatment. We present...
Purpose: To report a case of asymmetric bilateral optic neuropathy in a patient receiving tacrolimus...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Leukopenia in kidney transplant patients is frequent, it causes potentially life-threatening complic...
This study was designed to (a) estimate the contribution of tacrolimus nephrotoxicity to episodes of...
Tacrolimus is an immunosuppressive agent that inhibitscytokine synthesis and blocks T-cell developme...
International audienceWhilst calcineurin inhibitors (CNI) are the cornerstone of immunosuppressive m...
Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant afte...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
Tacrolimus is an immunosuppressive agent that can show a wide variety of neurological side effects, ...
Abstract Background Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological...
Guillain-Barré syndrome (GBS) has been described after solid organ and bone marrow transplantation m...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Patients, in particular recipients of orthotopic liver transplants, receiving the immunosuppressant ...
Tacrolimus is currently the most commonly prescribed immunosuppressant. Tacrolimus allowed intestina...
Introduction. Optic neuropathy is a rare but severe complication of tacrolimus treatment. We present...
Purpose: To report a case of asymmetric bilateral optic neuropathy in a patient receiving tacrolimus...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Leukopenia in kidney transplant patients is frequent, it causes potentially life-threatening complic...
This study was designed to (a) estimate the contribution of tacrolimus nephrotoxicity to episodes of...
Tacrolimus is an immunosuppressive agent that inhibitscytokine synthesis and blocks T-cell developme...
International audienceWhilst calcineurin inhibitors (CNI) are the cornerstone of immunosuppressive m...
Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant afte...